Alpha 2.0
Login Register
» Authors » Ahmed Eldefrawy

Ahmed Eldefrawy

Explore the profile of Ahmed Eldefrawy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 401
Followers 0
Related Specialties
Urology
Nephrology
Oncology
Top 10 Co-Authors
Murugesan Manoharan
Mark S Soloway
Ithaar H Derweesh
Margaret F Meagher
Aaron W Bradshaw
Fang Wan
Fady Ghali
Brittney H Cotta
Sunil H Patel
Devendar Katkoori
Published In
Urology
Cent European J Urol
Can J Urol
World J Urol
Urol Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
Avudaiappan A, Prabhakar P, Siretskiy R, Renshaw A, Eldefrawy A, Manoharan M
BJUI Compass . 2024 Nov; 5(11):1090-1094. PMID: 39539555
Background: Detecting carcinoma prostate (CaP) after intravesical Bacillus Calmette Guerin (BCG) immunotherapy for non-muscle invasive bladder cancer (NMIBC) poses diagnostic challenges. Granulomatous prostatitis (GP) has an incidence of 0.8%-3.3% in...
2.
A comparative study of survival outcomes between partial and radical cystectomy in octogenarians with muscle-invasive bladder cancer
Avudaiappan A, Prabhakar P, Lusnia C, Ganiyani M, Rubens M, Garje R, et al.
Transl Androl Urol . 2024 Sep; 13(8):1486-1497. PMID: 39280660
Background: Neoadjuvant chemotherapy with radical cystectomy (RC) is the preferred first-line treatment for localized muscle-invasive bladder cancer (MIBC). Due to the concern about morbidity associated with RC, the elderly population...
3.
Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study
Avudaiappan A, Prabhakar P, Sandman M, Rubens M, Garje R, Eldefrawy A, et al.
BMC Urol . 2024 Jul; 24(1):150. PMID: 39049001
Background: Neoadjuvant chemotherapy (NAC) with radical cystectomy (RC) is the preferred first-line treatment for localized muscle-invasive bladder cancer (MIBC). In recent years, octogenarians have been undergoing RC uneventfully, but studies...
4.
Irreversible electroporation as a focal therapy for localized prostate cancer: A systematic review
Prabhakar P, Avudaiappan A, Sandman M, Eldefrawy A, Caso J, Narayanan G, et al.
Indian J Urol . 2024 Feb; 40(1):6-16. PMID: 38314081
Introduction: Irreversible electroporation (IRE) is a new and promising focal therapy for the treatment of localized prostate cancer. In this systematic review, we summarize the literature on IRE for prostate...
5.
Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC)
Meagher M, Patil D, Saito K, Javier-DesLoges J, Bradshaw A, Patel S, et al.
Urology . 2022 Jan; 163:164-176. PMID: 34995562
Objective: To investigate association of African-American race and survival in Renal Cell Carcinoma (RCC). Patients And Methods: We queried the International Marker Consortium for Renal Cancer database for patients who...
6.
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)
Patel S, Derweesh I, Saito K, Patil D, Meagher M, Bindayi A, et al.
Clin Genitourin Cancer . 2021 Mar; 19(4):e206-e215. PMID: 33773937
Background: We sought to analyze the usefulness of pretreatment C-reactive protein (CRP) as a predictor of survival and oncological outcomes in patients with renal cell carcinoma (RCC). Methods: Retrospective international...
7.
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC)
Cotta B, Meagher M, Patil D, Saito K, Patel S, Patel D, et al.
BJU Int . 2020 Aug; 127(3):311-317. PMID: 32772468
Objective: To investigate association of preoperative C-reactive protein (CRP) and non-cancer mortality (NCM) in a cohort of patients undergoing surgery for localised renal cell carcinoma (RCC). Patients And Methods: Retrospective...
8.
Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database
Ryan S, Patel D, Ghali F, Patel S, Sarkar R, Yim K, et al.
Minerva Urol Nephrol . 2020 Aug; 73(2):233-244. PMID: 32748614
Background: The impact of positive surgical margins (PSM) on outcomes in partial nephrectomy (PN) is controversial. We investigated impact of PSM for patients undergoing PN on overall survival (OS) in...
9.
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis
Patel S, Uzzo R, Larcher A, Peyronnet B, Lane B, Pruthi D, et al.
Clin Genitourin Cancer . 2020 Jul; 18(6):e723-e729. PMID: 32600941
Background: The efficacy of partial nephrectomy (PN) in setting of pT3a pathologic-upstaged renal cell carcinoma (RCC) is controversial. We compared oncologic and functional outcomes of radical nephrectomy (RN) and PN...
10.
Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma
Meagher M, Lane B, Capitanio U, Mehrazin R, Bradshaw A, Noyes S, et al.
World J Urol . 2020 Jun; 39(4):1195-1201. PMID: 32556559
Purpose: To compare functional outcomes of partial nephrectomy (PN) and active surveillance (AS) in oncocytoma. Methods: Multicenter retrospective analysis of patients with oncocytoma managed with PN or AS (biopsy-confirmed). Primary...